Drug Wholesale Prices Impact Payer Spending, Out-of-pocket Costs
Increases in drug wholesale list prices have a trickle-down effect that negatively impacts patient financial responsibility, such as out-of-pocket costs, [...]
Bringing Value-Based Insurance Design to Oncology
Although the oncology field has been increasingly adopting value-based insurance designs, much work yet remains. For decades, the traditional dogma [...]
The Disturbing Dearth of Evidence for Supportive Oncology
Despite historical reliance on evidence generated from randomized controlled trials (RCTs), there has been a surge in the number of [...]
[Podcast] Telehealth, Standardizing Care, and Drug Prices in Oncology With Dr. Vincent Rajkumar
Tune to this podcast for a discussion on telehealth in oncology with Vincent Rajkumar, MD. As he lends his insights [...]
Pay-for-Performance Program Increased Evidence-Based Prescribing of Cancer Drugs
Increased prescribing rates of evidence-based cancer drugs may be achieved without a concomitant change in total spending on care through [...]
MDIC Releases Best Practices for Communicating Benefit, Risk, and Uncertainty for Medical Devices
The Medical Device Innovation Consortium (MDIC) released its report on of Best Practices for Communicating Benefit, Risk, and Uncertainty for [...]
